Amedisys (AMED) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
April 28, 2021 4:05 PM EDTBATON ROUGE, La., April 28, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2021.
Three-Month Periods Ended March 31, 2021 and 2020
Net service revenue increased $45.4Â million to $537.1Â million compared to $491.7Â million in 2020.Net income attributable to Amedisys, Inc. of $49.9Â million compared to $31.8Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.50 compared to $0.96 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $78.6Â million compared to $53.3Â million in 2020.Adjusted net income attributable to Amedisys, Inc. of $51.1Â million compared to... More